Its been a busy few months for RHY. And even though people will...

Its been a busy few months for RHY. And even though people will be smarting from the price drop following the TGA knock back - they have actually made some substantial progress towards revenue.
- Approval to sell Colostat in UK: this was far more than just filling out a sheet and paying 500 pound as the resident liar will have you believe. RHY are required to prove competency with their product according to UK's new rules.
- Strategic partner agreement - this will fast track their entry into the market place. All the paperwork is in place and LINK are clearly motivated to accelerate what is a brilliant product.
- Forum presentation in US - excellent opportunity to advance Colostat in one of the biggest markets, dominated by Insurance companies who will fall over themselves to find a cheaper way of trustworthy CRC screening, Which at the moment amounts to a very expensive colonoscopy.
- The company is in good financial shape and the intention is NOT have to return to the market for any further CR.
- New website up and running as they said it would.

Feel free to add on thoughts. Thought people might like something positive rather than listen to the jealous whining of a terminal downramper who is too gutless to take positions AND clearly doesnt have a clue about medical stock - or the stock market in general.